Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erin L Filbert

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Nature Reviews. Immunology|December 24, 2008
Scaffold proteins and immune-cell signallingAndrey S Shaw, Erin L Filbert
Plos One|February 23, 2013
Kinase suppressor of Ras 1 is not required for the generation of regulatory and memory T cellsMarie Le Borgne, Erin L Filbert, Andrey S Shaw
Cancer Immunology, Immunotherapy : CII|January 4, 2021
APX005M, a CD40 agonist antibody with unique epitope specificity and Fc receptor binding profile for optimal therapeutic applicationErin L Filbert, Pia K Björck, Minu K Srivastava, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 25, 2012
Stathmin regulates microtubule dynamics and microtubule organizing center polarization in activated T cellsErin L Filbert, Marie Le Borgne, Joseph Lin, et al.
European Journal of Immunology|September 25, 2010
Kinase suppressor of Ras 1 is required for full ERK activation in thymocytes but not for thymocyte selectionErin L Filbert, Anhco Nguyen, Mary A Markiewicz, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2011
Mutation that blocks ATP binding creates a pseudokinase stabilizing the scaffolding function of kinase suppressor of Ras, CRAF and BRAFJiancheng Hu, Haiyang Yu, Alexandr P Kornev, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 1, 2010
The death effector domain protein PEA-15 negatively regulates T-cell receptor signalingSandra Pastorino, Hemamalini Renganathan, Maisel J Caliva, et al.
Cancer Research Communications|January 5, 2024
Neoadjuvant CD40 Agonism Remodels the Tumor Immune Microenvironment in Locally Advanced Esophageal/Gastroesophageal Junction CancerMaira Soto, Erin L Filbert, Hai Yang, et al.
The Journal of Clinical Investigation|February 23, 2008
Growth hormone enhances thymic function in HIV-1-infected adultsLaura A Napolitano, Diane Schmidt, Michael B Gotway, et al.
Cancer Research Communications|February 5, 2025
A Phase 2 Study of Sotigalimab, a CD40 Agonist Antibody, plus Concurrent Chemoradiation as Neoadjuvant Therapy for Esophageal and Gastroesophageal Junction CancersAndrew H Ko, Joseph Chao, Marcus S Noel, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Nature Reviews. Immunology|December 24, 2008
Scaffold proteins and immune-cell signallingAndrey S Shaw, Erin L Filbert
Plos One|February 23, 2013
Kinase suppressor of Ras 1 is not required for the generation of regulatory and memory T cellsMarie Le Borgne, Erin L Filbert, Andrey S Shaw
Cancer Immunology, Immunotherapy : CII|January 4, 2021
APX005M, a CD40 agonist antibody with unique epitope specificity and Fc receptor binding profile for optimal therapeutic applicationErin L Filbert, Pia K Björck, Minu K Srivastava, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 25, 2012
Stathmin regulates microtubule dynamics and microtubule organizing center polarization in activated T cellsErin L Filbert, Marie Le Borgne, Joseph Lin, et al.
European Journal of Immunology|September 25, 2010
Kinase suppressor of Ras 1 is required for full ERK activation in thymocytes but not for thymocyte selectionErin L Filbert, Anhco Nguyen, Mary A Markiewicz, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2011
Mutation that blocks ATP binding creates a pseudokinase stabilizing the scaffolding function of kinase suppressor of Ras, CRAF and BRAFJiancheng Hu, Haiyang Yu, Alexandr P Kornev, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 1, 2010
The death effector domain protein PEA-15 negatively regulates T-cell receptor signalingSandra Pastorino, Hemamalini Renganathan, Maisel J Caliva, et al.
Cancer Research Communications|January 5, 2024
Neoadjuvant CD40 Agonism Remodels the Tumor Immune Microenvironment in Locally Advanced Esophageal/Gastroesophageal Junction CancerMaira Soto, Erin L Filbert, Hai Yang, et al.
The Journal of Clinical Investigation|February 23, 2008
Growth hormone enhances thymic function in HIV-1-infected adultsLaura A Napolitano, Diane Schmidt, Michael B Gotway, et al.
Cancer Research Communications|February 5, 2025
A Phase 2 Study of Sotigalimab, a CD40 Agonist Antibody, plus Concurrent Chemoradiation as Neoadjuvant Therapy for Esophageal and Gastroesophageal Junction CancersAndrew H Ko, Joseph Chao, Marcus S Noel, et al.
Pageof 1